What is Interstitial Cystitis
Though QSR concepts and CPG brands are expected to lose billions of dollars in revenue due to increased GLP-1 adoption, as Reuters reported, makers of tangy, sweet, and/or spicy sauces appear to be benefiting from the trend and recent M&A activity within the segment corroborates this assertion
Moshell AN, Parikh PD, Oetgen WJ
One real-world evidence study found that patients receiving GLP-1 receptor agonists had a higher risk of ulcerative colitis compared to those on DPP-4 inhibitors (a different diabetes drug class)
[DOI] [PMC free article] [PubMed] [Google Scholar] 194.Bethel M.A., Diaz R., Castellana N., Bhattacharya I., Gerstein H.C., Lakshmanan M.C
For help planning your dose escalation, use our free semaglutide dosage calculator